Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision label was updated to v3.6.6, signaling a small backend or display framework update. This change does not modify the study content or user-facing information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a minor site version update and does not modify the study details or how the page functions.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision label has been updated from v3.6.3 to v3.6.4. This indicates a small metadata update to the record rather than a change to study data or content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows a revision tag updated to v3.6.3, replacing the previous v3.6.2. This change signals a small platform/template revision rather than alterations to study details or content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays a revision label 'Revision: v3.6.2', replacing the previous 'Revision: v3.6.0'. This indicates a minor update to the ClinicalTrials.gov page.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now displays a clear recruitment status indicating that no participants are being sought, reflecting termination or halted accrual. It also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, indicating a page-wide content refresh.SummaryDifference0.4%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.